DoW Bone Marrow Failure, Idea Development Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Posted 17 Jun 2026 · 34 days left
In plain terms
The US Defense Health Agency funds innovative research ideas to understand and cure bone marrow failure diseases through its Idea Development Award, open to established and early-career investigators with no preliminary data requirement. Applications are due by 4 November 2026, and the programme total is 4 million US dollars.
A generated summary of the donor's text; the original wording is below.
Summary
Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases.
Distinctive Features:
This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers will assess Principal Investigators (PIs) using distinct review criteria based on their eligibility as an EI or ECI.
Preliminary data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Who can apply
- ngo_cso
- academia_research
- private_company
- government
- individual
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"